• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Too narrow and too broad: Differentiating late-onset dementia from its historical entanglement with Alzheimer's disease.

作者信息

Moseholm Kristine F, Tybjerg Karin, Jensen Majken K, Westendorp Rudi G J

机构信息

Section for Epidemiology, Department of Public Health, University of Copenhagen, Denmark.

Medical Museion, Department of Public Health, University of Copenhagen, Denmark.

出版信息

Aging Brain. 2021 Feb 19;1:100010. doi: 10.1016/j.nbas.2021.100010. eCollection 2021.

DOI:10.1016/j.nbas.2021.100010
PMID:36911504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9997125/
Abstract
摘要

相似文献

1
Too narrow and too broad: Differentiating late-onset dementia from its historical entanglement with Alzheimer's disease.过于狭窄与过于宽泛：区分迟发性痴呆与其与阿尔茨海默病的历史纠葛。
Aging Brain. 2021 Feb 19;1:100010. doi: 10.1016/j.nbas.2021.100010. eCollection 2021.
2
Familial clustering and genetic risk for dementia in a genetically isolated Dutch population.在一个基因隔离的荷兰人群中痴呆症的家族聚集性和遗传风险。
Brain. 2004 Jul;127(Pt 7):1641-9. doi: 10.1093/brain/awh179. Epub 2004 May 6.
3
Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients.早发型与晚发型阿尔茨海默病的葡萄糖代谢：对120例患者的统计参数映射分析
Brain. 2005 Aug;128(Pt 8):1790-801. doi: 10.1093/brain/awh539. Epub 2005 May 11.
4
Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia.日本阿尔茨海默病或血管性痴呆患者的载脂蛋白E多态性
J Neurol Neurosurg Psychiatry. 1994 Nov;57(11):1414-6. doi: 10.1136/jnnp.57.11.1414.
5
Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease.早发性与晚发性阿尔茨海默病的共病神经病理学诊断。
Brain. 2021 Aug 17;144(7):2186-2198. doi: 10.1093/brain/awab099.
6
Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies.老年期抑郁症与血管性痴呆和阿尔茨海默病风险：基于社区队列研究的系统评价和荟萃分析。
Br J Psychiatry. 2013 May;202(5):329-35. doi: 10.1192/bjp.bp.112.118307.
7
Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.突触核蛋白病生存及痴呆症发病的神经病理学和遗传学关联：一项回顾性分析
Lancet Neurol. 2017 Jan;16(1):55-65. doi: 10.1016/S1474-4422(16)30291-5.
8
Association of Late Life Depression, (Non-) Modifiable Risk and Protective Factors with Dementia and Alzheimer's Disease: Literature Review on Current Evidences, Preventive Interventions and Possible Future Trends in Prevention and Treatment of Dementia.老年期抑郁症、（不可）改变的风险和保护因素与痴呆和阿尔茨海默病的关联：当前证据、预防干预措施以及痴呆症预防和治疗的可能未来趋势的文献综述。
Int J Environ Res Public Health. 2020 Oct 14;17(20):7475. doi: 10.3390/ijerph17207475.
9
Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases.路易体痴呆的运动和认知功能：与阿尔茨海默病和帕金森病的比较。
J Neurol Neurosurg Psychiatry. 1997 Mar;62(3):243-52. doi: 10.1136/jnnp.62.3.243.
10
The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study.载脂蛋白 E 及其他常见遗传变异对阿尔茨海默病及痴呆发病的影响：基于社区的队列研究。
Lancet Neurol. 2018 May;17(5):434-444. doi: 10.1016/S1474-4422(18)30053-X. Epub 2018 Mar 16.

本文引用的文献

1
Biomarkers for Alzheimer's Disease (AD) and the Application of Precision Medicine.阿尔茨海默病（AD）的生物标志物与精准医学的应用
J Pers Med. 2020 Sep 21;10(3):138. doi: 10.3390/jpm10030138.
2
What if there's no such thing as "aging"?如果没有“衰老”这回事呢？
Mech Ageing Dev. 2020 Dec;192:111344. doi: 10.1016/j.mad.2020.111344. Epub 2020 Sep 16.
3
Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies.精准预防阿尔茨海默病和其他类型痴呆：在控制风险因素和实施疾病修饰疗法方面预测未来的需求。
Alzheimers Dement. 2020 Oct;16(10):1457-1468. doi: 10.1002/alz.12132. Epub 2020 Aug 20.
4
Expanded access: opening doors to personalized medicine for rare disease patients and patients with neurodegenerative diseases.扩大准入：为罕见病患者和神经退行性疾病患者打开通往个体化医学的大门。
FEBS J. 2021 Mar;288(5):1457-1461. doi: 10.1111/febs.15529. Epub 2020 Sep 5.
5
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.《痴呆症的预防、干预与照护：柳叶刀委员会2020年报告》
Lancet. 2020 Aug 8;396(10248):413-446. doi: 10.1016/S0140-6736(20)30367-6. Epub 2020 Jul 30.
6
Clinical Trials in Alzheimer's Disease: A Hurdle in the Path of Remedy.阿尔茨海默病的临床试验：治疗道路上的一个障碍。
Int J Alzheimers Dis. 2020 Apr 1;2020:5380346. doi: 10.1155/2020/5380346. eCollection 2020.
7
2020 Alzheimer's disease facts and figures.2020年阿尔茨海默病事实与数据。
Alzheimers Dement. 2020 Mar 10. doi: 10.1002/alz.12068.
8
Reasons for Failed Trials of Disease-Modifying Treatments for Alzheimer Disease and Their Contribution in Recent Research.阿尔茨海默病疾病修饰治疗试验失败的原因及其在近期研究中的作用。
Biomedicines. 2019 Dec 9;7(4):97. doi: 10.3390/biomedicines7040097.
9
Ageing as a risk factor for neurodegenerative disease.衰老作为神经退行性疾病的一个风险因素。
Nat Rev Neurol. 2019 Oct;15(10):565-581. doi: 10.1038/s41582-019-0244-7. Epub 2019 Sep 9.
10
Dementia: Paradigm shifting into high gear.痴呆症：范式转变进入高速档。
Alzheimers Dement. 2019 Jul;15(7):985-994. doi: 10.1016/j.jalz.2019.01.006. Epub 2019 Apr 9.